(Q38154625)

29 August 2017

Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach (English)

1 reference

29 August 2017

Marco A Grados

1

1 reference

29 August 2017

Matt W Specht

series ordinal

2

1 reference

29 August 2017

Hyung-Mo Sung

series ordinal

3

1 reference

29 August 2017

Diandra Fortune

series ordinal

4

1 reference

29 August 2017

language of work or name

English

0 references

publication date

23 October 2013

1 reference

Expert Opinion on Drug Discovery

29 August 2017

1 reference

29 August 2017

8

1 reference

29 August 2017

12

1 reference

29 August 2017

1515-1527

1 reference

Ion channels and epilepsy

29 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Topiramate: a new antiepileptic drug for refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

GSH rescue by N-acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

D-amino acids as putative neurotransmitters: focus on D-serine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Physiological relevance of endogenous free D-serine in the mammalian brain: are scientists on a royal road for the treatment of glutamatergic-related brain disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Ketamine: new indications for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Neurotransmitters and apoptosis in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Drugs of abuse that cause developing neurons to commit suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Postmortem brain abnormalities of the glutamate neurotransmitter system in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Neuroprotective agents in schizophrenia and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Twenty-five years of glutamate in schizophrenia: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Excitotoxicity: bridge to various triggers in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Ionotropic glutamate receptors: regulation by G-protein-coupled receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Cholesterol loss during glutamate-mediated excitotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Anticonvulsants: aspects of their mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The attention system of the human brain: 20 years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The orbitofrontal cortex and beyond: from affect to decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The way of our errors: theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The pharmacology and mechanism of action of riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate inhibition in MS: the neuroprotective properties of riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Riluzole in psychiatry: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutathione: overview of its protective roles, measurement, and biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The promise of N-acetylcysteine in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Structure and mechanism of a glutamate-GABA antiporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The central role of glutathione in the pathophysiology of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Modulation of glutamate receptor functions by glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Adverse reactions associated with acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Quality of life in obsessive-compulsive disorder: an evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Effect of electrical stimulation and high potassium concentrations on the effux of (14C) glycine from slices of spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate binding-site ligands of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glycine as a neurotransmitter in the forebrain: a short review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Ketamine as a novel antidepressant: from synapse to behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Intravenous ketamine for treatment-resistant major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Investigational NMDA receptor modulators for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Effects of ketamine in treatment-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Acamprosate Is Neuroprotective Against Glutamate-Induced Excitotoxicity When Enhanced by Ethanol Withdrawal in Neocortical Cultures of Fetal Rat Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Homeobox genes in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The SLC1 high-affinity glutamate and neutral amino acid transporter family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

mTOR: on target for novel therapeutic strategies in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Regulation of glutathione synthesis via interaction between glutamate transport-associated protein 3-18 (GTRAP3-18) and excitatory amino acid carrier-1 (EAAC1) at plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Modulation of neuronal glutathione synthesis by EAAC1 and its interacting protein GTRAP3-18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Activity regulation of adenosine deaminases acting on RNA (ADARs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Genetic manipulation of key determinants of ion flow in glutamate receptor channels in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Adar is essential for optimal presynaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Activity-regulated RNA editing in select neuronal subfields in hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Functional coupling between ryanodine receptors and L-type calcium channels in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Calcium mobilization by ryanodine promotes the phosphorylation of initiation factor 2alpha subunit and inhibits protein synthesis in cultured neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Calcium leak through ryanodine receptor is involved in neuronal death induced by mutant huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

PCB-95 promotes dendritic growth via ryanodine receptor-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Expression of Meis and Pbx genes and their protein products in the developing telencephalon: implications for regional differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The hexapeptide LFPWMR in Hoxb-8 is required for cooperative DNA binding with Pbx1 and Pbx2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Hoxb8 is required for normal grooming behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Hematopoietic origin of pathological grooming in Hoxb8 mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Targeting metabotropic glutamate receptors in neuroimmune communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate joins the ranks of immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Synaptic scaffold evolution generated components of vertebrate cognitive complexity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Proteomic analysis of NMDA receptor-adhesion protein signaling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Concepts in sumoylation: a decade on

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

21 January 2018

Decoding the SUMO signal

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive-compulsive disorder with compulsive hoarding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

The Effect of Riluzole Augmentation in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder, Taking Two Other Glutaminergic Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.845553

10.1517/17460441.2013.845553

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference